Visit Evonik’s website at http://corporate.evonik.com/en/Pages/default.aspx
Celonic is a privately owned CDMO based in Basel, Switzerland, providing comprehensive GMP development and manufacturing services for New Biological Entities (NBEs) and Biosimilars, worldwide. The services includes the development of cell lines, production processes, as well as the GMP and non-GMP manufacturing of biopharmaceutical drugs.
Visit Celonic’s website at www.celonic.com.
BioGenes GmbH, a world-wide acting full-service provider for customized immunoassay and antibody development, and trenzyme enjoy a long history of successful collaboration in the field of recombinant protein production and antibody generation.
trenzyme’s long-standing expertise in recombinant protein production in connection with BioGenes’s extensive antibody know-how for complex antibody development, allows trenzyme to offer a high quality all-around-carefree package from cloning to final antibody generation for it’s clients.
BioGenes is certified to meet the international requirements and regularities of quality assurance and animal welfare and maintains long-term alliances with biotech and pharmaceutical companies as well as research institutes all over the world.
Visit BioGenes’s website at http://www.biogenes-antibodies.com/
Visit Lonza’s website at www.lonza.com
Oxford Expression Technologies Ltd (OET) and trenzyme GmbH, both experts in the field of recombinant protein expression, have agreed to collaborate so that the full potential of their complementary technologies can be realized.
Under terms of the collaboration, both companies will be able to offer a full range of recombinant protein expression services across a variety of platforms including baculovirus, yeast, bacterial and mammalian systems. The collaboration offers exciting possibilities in the field of the rapidly developing BacMam system, in which baculoviruses are used for protein production in mammalian cell lines. The BacMam system increases the options available to improve both the yield and quality of recombinant proteins. It also has applications in therapeutic fields including the production of recombinant vaccines and gene delivery into human cells. Furthermore, the BacMam system fits perfectly to the Cross Organism Expression platform of trenzyme allowing the fast and reliable screening of the best expression host for a given target protein in respect of timelines, yield and quality.
Visit Oxford Expression Technologies’s website at www.oetltd.com.
trenzyme collaborates with GATC Biotech in the field of stable cell line development, as GATC provides the MYCOPLASMACHECK for quality control of cell lines. In addition GATC Biotech is trenzyme’s preferred partner for all DNA sequencing jobs.
Limsophy supports cross-departmental thinking and acting. ‘Philosophy of Limsophy’ means integrated information management. It is important that data crosses departments unobstructed and is made available to each department in its appropriate form. Limsophy simplifies the transformation of data into information and knowledge.
Visit AAC Infotray’s website at http://www.limsophy.com/home
trenzyme and Assy.Works collaborate in the field of customized screening projects using protein or stable mammalian cell lines.
Visit Assay.Works’s website at http://www.assay.works/#home
Visit BioLAGO’s website at www.biolago.org/en/home/
For more information visit www.steinbeis.de/su/2044